Good Cancer Control, Survival With SBRT for Limited Metastatic/Progressive Disease



(MedPage Today) — Patients with limited metastatic/progressive cancers had good rates of local control and favorable survival with stereotactic body radiotherapy (SBRT) and no systemic therapy, according to a multicenter retrospective study from…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/117929

Author :

Publish date : 2025-10-13 21:25:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version